FIELD: medicine.
SUBSTANCE: invention relates to biotechnology and represents method of inhibiting or neutralisation of induction or secretion of HAS2, HA, CD44 or RHAMM by native polypeptide of domain 1 WISP-1 of humans in mammalian cells of, at least, one type. Also, by means of said polypeptide realised is method of treating various types of cancer in mammals and method of inhibiting cancer cell mobility. Invention also relates to application of polypeptide of domain 1 WISP 1 in production of medications for inhibition or neutralisation of induction or secretion of HAS2, HA, CD44 and RHAMM, for inhibiting cancer cells mobility, as well as for cancer treatment.
EFFECT: invention can be efficiently used in prevention and treatment of various types of cancer.
25 cl, 96 dwg, 1 tbl, 29 ex
| Title | Year | Author | Number |
|---|---|---|---|
| WNT ANTAGONISTS AND METHODS OF TREATING AND TESTING | 2011 |
|
RU2593947C2 |
| AGENTS LINKING FRIZZLED RECEPTOR AND THEIR USE | 2009 |
|
RU2579897C2 |
| INHIBITION OF DISSEMINATION OF TUMOUR USING Bv8 OR G-CSF ANTAGONISTS | 2010 |
|
RU2567803C2 |
| METHODS OF APPLYING OF APO-2L-RECEPTORS AGONISTS AND NK-CELLS ACTIVATORS | 2005 |
|
RU2395294C2 |
| METHODS OF INHIBITING OCULAR ANGIOGENESIS | 2009 |
|
RU2530583C2 |
| ALK1 ANTAGONISTS AND THEIR APPLICATION IN THE TREATMENT OF KIDNEY-CELLULAR CARCINOMA | 2013 |
|
RU2633638C2 |
| ANTAGONISTS OF ALK1 RECEPTOR AND LIGANDS AND THEIR APPLICATION | 2007 |
|
RU2559532C2 |
| ANGIOGENESIS INHIBITION | 2008 |
|
RU2471498C2 |
| COMPOSITIONS AND METHODS FOR REGULATION OF VESSELS DEVELOPMENT | 2005 |
|
RU2365382C2 |
| METHOD FOR INHIBITION OF HEPATOCYTE PROLIFERATION, METHOD FOR INHIBITION OF HEPATOCYTE CELL ADHESION AND METHOD FOR INHIBITION OF BIOLOGICAL ACTIVITY ANGPTL4 IN HEPATOCYTES OR HEPATOCYTE PRECURSORS | 2005 |
|
RU2380411C2 |
